Zhaoke Ophthalmology Ltd. (6622)

Overview

Zhaoke Ophthalmology Limited is a leading ophthalmic pharmaceutical company dedicated to the research, development, and commercialization of innovative therapies that aim to meet unmet medical needs within the ophthalmology field in the People's Republic of China. The company, which was previously known as China Ophthalmology Focus Limited, has established its name in the industry since its inception in 2017. With its headquarters located in Guangzhou, Zhaoke Ophthalmology Limited focuses on bringing advanced treatment solutions for various eye diseases, leveraging its significant research and development capabilities to impact the ophthalmic care landscape positively.

Products and Services

As part of its mission to address the spectrum of eye health issues faced by patients, Zhaoke Ophthalmology Limited is renowned for its development of a wide range of drug candidates targeting critical ophthalmic conditions. These include:

• Dry Eye Diseases: The company is working on innovative treatment solutions that aim to offer relief and improve the quality of life for patients suffering from dry eye conditions, a prevalent and often discomforting issue.
• Wet Age-Related Macular Degeneration (Wet AMD): Focusing on one of the leading causes of vision loss among the elderly, Zhaoke Ophthalmology Limited is developing drugs designed to treat and manage wet AMD, offering hope to those affected by this degenerative condition.
• Diabetic Macular Edema (DME): With the rise of diabetes globally, DME has become a common complication that can lead to blindness. The company is dedicated to creating therapies that help manage and treat this challenging condition, aiming to preserve and possibly improve vision in affected individuals.
• Myopia: Recognizing the growing epidemic of myopia or nearsightedness, especially in children and adolescents, Zhaoke Ophthalmology Limited is developing treatments that not only aim to control but also reverse the progression of myopia, promoting better eye health for future generations.
• Glaucoma: Known as the "silent thief of sight," glaucoma can lead to irreversible vision loss if not treated timely. The company is actively pursuing innovative solutions to manage and treat glaucoma, to slow or prevent the progression of this condition.